Dan Frigo, University of Houston (IMAGE) University of Houston Caption Receiving two grants within a week of each other, Dan Frigo is targeting two different mechanisms that play a role in prostate cancer. Both focus on a cascade of biochemical reactions inside cells, downstream of a protein called the androgen receptor (AR). Credit Jessie Villarreal Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.